SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Ryerson Holding Corporation (RYI) , forward earnings yield 5.44%. PEG 0.54 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.54); analyst target implies upside (+57.5%).
- Forward P/E 18.4
- PEG Ratio 0.54 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Analyst consensus target $36.50 (+57.5% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 42/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — RYI
Valuation Multiples
P/E (TTM)0.0
Forward P/E18.4
PEG Ratio0.54
Forward PEG0.54
P/B Ratio0.00
P/S Ratio0.16
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.75
Forward EPS (Est.)$1.26
Book Value / Share$0.00
Revenue / Share$142.08
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield5.44%
Dividend Yield0.00%
Analyst Target$36.50 (+57.5%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.54 |
$2.86B |
$18.7M |
0.7% |
| 2017 |
$0.46 |
$3.36B |
$17.1M |
0.5% |
| 2018 |
$2.81 |
$4.41B |
$106M |
2.4% |
| 2019 |
$2.17 |
$4.5B |
$82.4M |
1.8% |
| 2020 |
$-1.72 |
$3.47B |
$-65.3M |
-1.9% |
| 2021 |
$7.56 |
$5.68B |
$294.3M |
5.2% |
| 2022 |
$10.21 |
$6.32B |
$391M |
6.2% |
| 2023 |
$4.10 |
$5.11B |
$145.7M |
2.9% |
| 2024 |
$-0.26 |
$4.6B |
$-8.6M |
-0.2% |
| 2025 |
$-1.75 |
$4.57B |
$-56.4M |
-1.2% |
